Aim: To evaluate the efficacy and safety of biphasic insulin aspart during first 2 to 8 days of hospital admission of patients with type 2 diabetes (T2DM) for non-glycemia related medical ailments.

Methods: An open-label, non-randomized, observational, single-center study in patients with T2DM aged between 18 and 70 years at a tertiary multispecialty hospital in India. T2DM patients with capillary blood glucose (BG) between 70 mg/dl to 400 mg/dl at admission, requiring subcutaneous biphasic insulin aspart were included in this study. Insulin dosage was individualized as per the clinician’s judgement considering the clinical status, HbA1c and other co-morbidities. The primary endpoint was mean capillary BG levels at fasting, prelunch, predinner and at midnight during day 2 to day 8 of hospital stay. Secondary endpoints were frequency and severity of hypoglycemic episodes. Appropriate statistics were applied at 2-tailed p ≤0.significance.

Results: Total 2T2DM patients were included in this study. Median age was 57 years, 66.3% male and 33.7% female. Mean duration of T2DM was 9.9 years, HbA1c 7.3%, BMI 25.9 kg/m2 and hospital stay 8.9 days. The mean (SD) BG at admission was 208.5 (82.9) mg/dL and after usage of Biphasic Insulin Aspart 188.2 (45.3) mg/dL. Mean capillary BG levels at fasting, prelunch, predinner, and at midnight were 166.9 (46.7) mg/dL, 201.0 (58.8) mg/dL, 203.9 (60.1) mg/dL, and 179.0 (48.7) mg/dL respectively. BG readings that met the target BG range (140-180 mg/dL) levels were 34.6%. During the study 5.9% of patient’s experienced hypoglycemic event of which 2% were severe requiring intravenous dextrose and 3.9% were mild. There was a significant difference in BG reduction correlating with BMI, HbA1c (p =0.05).

Conclusions: Treatment with biphasic insulin aspart is observed to be effective in achieving optimal BG levels, is well-tolerated with low hypoglycemic events in patients admitted in hospital for non-glycemia related medical ailments.


R.S. Erukulapati: None. A. Yerramilli: None. V. Kancherla: None. G.S. Sreelalitha: None. A. Poojari: None. F.Z. Khan: None. K. Chappidi: None.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at